Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer

Abstract
Publication Date:
2014
Iris type:
01.05 Abstract in rivista
List of contributors:
Authors of the University:
Handle:
https://iris.cnr.it/handle/20.500.14243/273626
Published in:
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
Journal